A method is provided for treating diabetes and related diseases employing an SGLT2 inhibiting amount of a compound of the formula ##STR1## alone or in combination with one or more other antidiabetic agent(s) or other therapeutic agent(s).
A method is provided for treating diabetes and related diseases employing an SGLT2 inhibiting amount of a compound of the formula ##STR1##
alone or in combination with one or more other antidiabetic agent(s) or other therapeutic agent(s).
Web www.patentalert.com
< OB fusion protein compositions and methods
< Corticotropin releasing factor 2 receptor agonists
> Piperidine-piperazine ligands for neurotransmitter receptors
> Ligands of adenine nucleotide translocase (ANT) and compositions and methods related thereto
HOME | NEW USER | LOGIN | SUBSCRIPTIONS | SEARCH | GUESTBOOK | CONTACT
